USPTO 2015–2025 USPTO PatentsView Foreign Corporation

Global Life Sciences Solutions Operations UK Limited

USPTO PatentsView assignee record - 30 granted patents across 18 technology areas, recorded in grant years 2020–2025. Grant-trend analysis is cross-referenced to USPTO Patent Public Search; it does not measure application filings, current R&D, or legal strength. Primary class: C12Q (Measuring OR Testing Processes Involving Enzymes, Nucleic Acids OR Microorganisms ; Compositions OR Test Papers THEREFOR; Processes OF Preparing Such COMPOSITIONS; Condition-responsive Control IN Micr).

RSS updates for this company

The verdict

According to USPTO PatentsView, Global ranks #10,336 of 49,997 tracked US assignees by granted-patent volume, with 30 patents across 18 technology areas.

#10,336
of 49,997 US assignees by volume
Top 33%
by Innovation Score (41.4/100)
14.6
avg claims per patent

USPTO PatentsView assignee plate

Corpus R10336 · Foreign Corporation #10,336 · 30 grants

GRANTS-SMALL · UPPER-Q · PHOTO-FINISH · CPC-FOCUS · INNOV-PAR · CLAIMS-RICH · TYPE-FRNCORP · SPAN-YRS · BOOK-RICH

  • GRANTS-SMALL 30 grants
  • UPPER-Q #10,336/49,997
  • PHOTO-FINISH Genelec Oy
  • CPC-FOCUS C12Q · 18 areas
  • INNOV-PAR 41.4/100
  • CLAIMS-RICH 14.6 claims/avg
  • TYPE-FRNCORP Foreign Corp
  • SPAN-YRS 2020–2025 · 6y
  • BOOK-RICH 9/10 fields

Nearest grant-volume peer: Genelec Oy (±0 grants)

Instrument codes from this assignee’s USPTO PatentsView grant sheet: volume band, corpus rank, photo-finish peer, lead CPC, Innovation Score, claim depth, assignee type, velocity, and book completeness. Not a USPTO rating of patent strength.

How Global’s 41.4 Innovation Score adds up

The same four weighted components behind every Innovation Score on PlainPatent: portfolio volume, grant velocity, technology breadth, and claim depth.

Innovation-score neighbourhood around Global

Lowest and highest poles plus nearest Innovation Score peers, not a full corpus board reprint.

score

What this shows Global's Innovation Score is 41.4/100 (top 33% of the PatentsView-derived corpus). The chart places that score against the nearest Innovation Score peers plus corpus poles, not a reprint of the volume ranking.

Source USPTO PatentsView, PlainPatent Innovation Score As of 2015–2025

Does more volume mean deeper claims for Global?

Each dot is one of Global’s 8 nearest volume peers (same corpus rank neighbourhood as the chart above), placed by total granted patents (horizontal) against average claims per patent (vertical). Global’s own 14.6 claims/patent is ABOVE the 14.2 median for these volume peers. More thorough claims than most filers at this scale, not just more of them.

Global vs its 8 nearest volume peers: granted patents vs average claims per patent. Source: USPTO PatentsView. 2×2 strategic matrix plotting 9 entities by Granted patents (volume) (X) and Avg claims / patent (Y), with a crosshair dividing the plot into four quadrants. Volume + depthSelective & thoroughVolume over depthLean filer 29.93030.1 0510152025 Granted patents (volume) Avg claims / patent Genelec Oy - 30, 14.63Genelec OyGetGo, Inc. - 30, 19.97GetgoGibbs Technologies Limited - 30, 21.6GibbsGlashütter Uhrenbetrieb GmbH - 30, 7Glashütter Uhrenb…Gold Bond Building Products, LLC - 30, 18.7Gold Bond Buildin…Hangzhou Biotest Biotech Co., Ltd. - 30, 5.63Hangzhou Biotest…Haulotte Group - 30, 12.13Haulotte GroupHerrenknecht Aktiengesellschaft - 30, 14.17Herrenknecht Akti…Global Life Sciences Solutions Operations UK Limited - 30, 14.6Global Life Scien…
Global vs its 8 nearest volume peers: granted patents vs average claims per patent. Source: USPTO PatentsView.

Where Global's grants concentrate

Global Life Sciences Solutions Operations UK Limited is a focused PatentsView assignee: 18 CPC subclasses with 50% of grants classified under C12Q (Measuring OR Testing Processes Involving Enzymes, Nucleic Acids OR Microorganisms ; Compositions OR Test Papers THEREFOR; Processes OF Preparing Such COMPOSITIONS; Condition-responsive Control IN Micr). Peak complete grant year is 2021 (11 grants) versus a trough of 3 in 2024. By volume, Global sits between Genelec Oy and Herrenknecht Aktiengesellschaft.

Global's three-year grant acceleration

Global Life Sciences Solutions Operations UK Limited shows 13 grants in 2022–2024 against only 15 in 2019–2021. That prior window is too thin for a growth multiple (rename and spin-out assignees look artificially high when the baseline is near zero), so PlainPatent withholds a ranked acceleration claim here.

Who files at Global's volume?

Granted US patents 2015–2025 versus its nearest-ranked assignees by volume, this company marked ◀

patents

What this shows Global holds 30 patents at rank #10,338, shown against the 8 assignees closest to it in grant volume rather than the industry's largest filers.

Source USPTO PatentsView, granted utility patents As of 2015–2025

Companies ranked near Global

By rank, the assignees closest to #10,338 in granted patent volume.

Leaders in C12Q (Measuring OR Testing Processes Involving Enzymes)

Other assignees with the most granted patents in Global's primary technology class.

Assignees with similar portfolio profiles

Two PlainPatent-derived peer sets for Global, neither rank-band nor same-CPC leaders (those blocks stay above). In C12Q (Measuring OR Testing Processes Involving Enzymes), Global ranks #309 of 2,502 assignees by patent count in that subclass.

Global's Innovation Score vs. every tracked assignee

Composite of portfolio volume, grant velocity, technology breadth, and claim depth (0–100)

41 Top 33% higher than 67% of 49,997 US assignees

This assignee 0 100 every tracked assignee, bucketed by value

Each bar is a band; taller bars hold more US assignees. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count, share, and where it sits relative to this entry.

Source USPTO PatentsView, PlainPatent Innovation Score · 2015–2025

024681012 202020212022202320242025 2
USPTO utility patent grants by year · 2020–2025

Grants by year

Teal-shaded recent years (2020–present) versus the 2020–2019 baseline. Full figures in the table below.

View data table
Global Life Sciences Solutions Operations UK Limited patent grants by year, 2015–2025
Year Patents Granted Share of Period
2020 4 13.3%
2021 11 36.7%
2022 4 13.3%
2023 6 20.0%
2024 3 10.0%
2025partial year 2 6.7%

Which technologies does Global Life Sciences Solutions Operations UK Limited patent most?

Top 15 of 18 technology areas

More on this record

Data Source

USPTO PatentsView, US granted patents 2015–2025

What to do with this data

Global Life Sciences Solutions Operations UK Limited's patent record in context - here's where to go next.

  • Global Life Sciences Solutions Operations UK Limited's lead technology class is C12Q (Measuring OR Testing Processes Involving Enzymes, Nucleic Acids OR Microorganisms ; Compositions OR Test Papers THEREFOR; Processes OF Preparing Such COMPOSITIONS; Condition-responsive Control IN Micr), 50% of its portfolio - see every assignee active in that class. Explore C12Q
  • Ranked #10,336 of 49,997 tracked assignees by patent volume - see the full leaderboard. See the ranking
  • Compare Global Life Sciences Solutions Operations UK Limited against Genelec Oy, an assignee filing at a similar volume. Compare portfolios
  • Innovation Score of 41.4/100 blends volume, velocity, technology breadth, and claim depth. How it's calculated

Figures reflect USPTO PatentsView grant data through May 2026; pending applications not yet granted are not counted.

Every figure on PlainPatent is rendered directly from USPTO source data, no number is typed in by an editor. This page draws directly on USPTO source data, no figure is typed in by an editor. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error. Data current as of May 2026.